
mRNA-1083 Effective and Safe for Adults Aged 50+ Against Flu and COVID-19, Phase 3 Trial Reveals
USA: A new phase 3 clinical trial has found that a single multi-component mRNA vaccine targeting both seasonal influenza and COVID-19 is not only well-tolerated but also produces immune responses on par with, or even better than, current standard …